Drug biophysical profiling using lipid-based colloidal nanosystems and human serum albumin as biomimetic interfaces
The development of new drugs is a highly complex and expensive process, so it is crucial that less promising compounds are rejected early in the discovery phase before progressing to more expensive phases. This scenario impels researchers to refine and speed up the drug discovery process and to seek...
| Autor principal: | |
|---|---|
| Outros Autores: | , , , , |
| Formato: | conferenceObject |
| Idioma: | eng |
| Publicado em: |
2017
|
| Assuntos: | |
| Texto completo: | http://hdl.handle.net/1822/49668 |
| País: | Portugal |
| Oai: | oai:repositorium.sdum.uminho.pt:1822/49668 |